Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | NQO2 | P16083 | 1/20 | 0.61 |
| ▸ | RELA | Q04206 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | ERN1 | O75460 | 1/20 | 0.57 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29950410 | 1.00 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| Formaldehyde SCHEMBL8164524 | 0.93 | NPC1 (0.59) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL340086 | 0.84 | NPC1 (0.60) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL8440252 | 0.82 | NPC1 (0.61) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL29763172 | 0.82 | NPC1 (0.61) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL581508 | 0.80 | TUBB4A (0.63) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL929945 | 0.80 | CYP3A4 (0.56) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL172689 | 0.80 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL15086617 | 0.80 | CYP1A2 (0.60) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA | |
| SCHEMBL595280 | 0.80 | MAOB (0.64) | ALDH1A1SMN1; SMN2KDM4EMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117558791-B | Light high-light-transmittance photovoltaic backboard and preparation method thereof | 温州鑫泰新材料股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117558791-A | Light high-light-transmittance photovoltaic backboard and preparation method thereof | 温州鑫泰新材料股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| US-20230340180-A1 | AROMATIC POLYOL-STABILIZED RESOL RESIN | SAINT-GOBAIN ISOVER (FR) | 2023-10-26 | — | — | US | claimed |
| EP-4172126-A1 | AROMATIC POLYOL-STABILIZED RESOL RESIN | SAINT-GOBAIN ISOVER (FR) | 2023-05-03 | — | — | EP | claimed |
| CN-114146071-B | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome | 西北农林科技大学深圳研究院 | 2023-02-28 | — | — | CN | claimed |
| CN-112457472-B | Low-viscosity bio-based magnolol epoxy resin and preparation method thereof | 广东工业大学 | 2022-10-04 | — | — | CN | claimed |
| CN-111995865-B | Polymer material, preparation method thereof and manufacturing method of polymer product | 湖南华曙高科技股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-114146071-A | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome | 西北农林科技大学深圳研究院 | 2022-03-08 | — | — | CN | claimed |
| WO-2022003289-A1 | AROMATIC POLYOL-STABILIZED RESOL RESIN | SAINT-GOBAIN ISOVER (FR) | 2022-01-06 | — | — | WO | claimed |
| CN-112625691-A | Soil deodorant and preparation method and application thereof | 浙江浙聚科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| US-20160030437-A1 | TAU AGGREGATION INHIBITOR | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2016-02-04 | — | — | US | claimed |
| EP-2962687-A1 | TAU AGGREGATION INHIBITOR | The Doshisha (JP) | 2016-01-06 | — | — | EP | claimed |
| CN-104119921-A | Etching paste composition and application thereof | CHI MEI CORP | 2014-10-29 | — | — | CN | claimed |
| US-7807740-B2 | Two-component reaction resin and method of fastening using the resin | HILTI AKTIENGESELLSCHAFT (LI) | 2010-10-05 | — | — | US | claimed |
| US-20080171807-A1 | Two-component reaction resin and method of fastening using the resin | HILTI AKTIENGESELLSCHAFT (LI) | 2008-07-17 | — | — | US | claimed |
| EP-1476549-B1 | METHODS FOR TWO-DIMENSIONAL CONFORMATION-DEPENDENT SEPARATION OF NON-CIRCULAR NUCLEIC ACIDS | LIFEIND EHF (IS) | 2008-06-04 | — | — | EP | claimed |
| EP-0262061-B1 | PROCESS FOR STABILIZING CHLORINATION MIXTURES OF PHENOL AND/OR CHLOROPHENOLS | RHONE-POULENC CHIMIE (FR) | 1993-02-24 | — | — | EP | claimed |
| US-4853153-A | USING REDUCING AGENT AND CHLORINATED CYCLIC KETONE | RHONE-POULENC CHIMIE (FR) | 1989-08-01 | — | — | US | claimed |
| US-4746322-A | Hair dye composition and process for using the same | REPLIGEN CORPORATION (US) | 1988-05-24 | — | — | US | claimed |
| US-3930862-A | DYE DEVELOPER TRANSFER PHOTOSENSITIVE MATERIAL WITH SUBSTITUTED CATECHOL AUXILIARY DEVELOPER | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030437-A1 | TAU AGGREGATION INHIBITOR | MAPT, PSEN2, PSEN1 | ALDH1A1 4120/4885SMN1; SMN2 202/4885KDM4E 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.